Poniard Pharmaceuticals, Inc.

PARD · OTC
Analyze with AI
12/31/2010
12/31/2009
12/31/2008
12/31/2007
Assets
Cash & Equivalents$1,284$15,938$44,144$29,335
Short-Term Investments$3,046$27,451$28,611$63,286
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$887$1,107$1,258$1,236
Total Curr. Assets$5,217$44,496$74,013$93,857
Property Plant & Equip (Net)$49$219$1,123$1,121
Goodwill$0$0$0$0
Intangibles$6,377$7,592$8,807$10,021
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$135$289$141
Total NC Assets$6,426$7,946$10,219$11,283
Other Assets$0$0$0$0
Total Assets$11,643$52,442$84,232$105,140
Liabilities
Payables$392$849$604$677
Short-Term Debt$0$8,599$7,950$4,247
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,224$7,679$10,586$4,550
Total Curr. Liab.$1,616$17,127$19,140$9,474
LT Debt$1,574$11,671$17,445$6,561
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,574$11,671$17,445$6,561
Other Liabilities$0$0$0$0
Cap. Leases$1,574$1,485$70$0
Total Liabilities$3,190$28,798$36,585$16,035
Equity
Pref Stock$2$4$4$4
Common Stock$971$842$694$693
Retained Earnings-$438,943-$408,156-$361,941-$312,817
AOCI$8-$17-$354$0
Other Equity$446,415$430,971$409,244$401,225
Total Equity$8,453$23,644$47,647$89,105
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$11,643$52,442$84,232$105,140
Net Debt$290$4,332-$18,749-$18,527